PMID: 16508428Mar 2, 2006Paper

Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation

Retina
Prithvi MruthyunjayaS Fekrat

Abstract

To describe the clinical features of persons who developed central retinal vein occlusion (CVO) while being treated with Coumadin for chronic anticoagulation. In a retrospective, comparative, noninterventional case series of patients diagnosed with CVO while being treated with Coumadin as a systemic anticoagulant, visual and anatomical outcomes were compared with those for a cohort of patients diagnosed with CVO who were not treated with any systemic anticoagulation. Fourteen eyes of 14 patients treated with Coumadin were identified. At presentation, the median international normalization ratio (INR) was 2.20 (range, 1.3-5.0). Eight patients (57%) had a therapeutic INR at the time of CVO. Their visual acuity and perfusion status were similar to those of patients with subtherapeutic INR. At the last follow-up (median, 16 months), visual acuity and perfusion status of the group of 14 eyes were similar to baseline findings (P = 0.62). Clinical features and outcomes were similar to those for a cohort of patients with CVO who were not being treated with systemic anticoagulation. CVO can occur in patients being treated with Coumadin for systemic anticoagulation. Final visual acuity and perfusion status were similar to those in a coho...Continue Reading

References

Oct 15, 1994·American Journal of Ophthalmology·A Glacet-BernardM M Samama
Mar 5, 1998·The British Journal of Ophthalmology·M Greaves
May 6, 1998·Indian Journal of Ophthalmology·K S Sangha
Mar 18, 1999·Ophthalmology·S C RajaN M Bressler
Aug 4, 1999·Documenta Ophthalmologica. Advances in Ophthalmology·A M Abu El-AsrarA K Al-Momen
Feb 13, 2001·American Journal of Ophthalmology·S S HayrehP Podhajsky
Mar 13, 2001·Chest·P A Howard, M I Dunn
Apr 6, 2002·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh HayrehPatricia Podhajsky
Jun 5, 2004·Ophthalmology·David J Browning, Christina M Fraser

❮ Previous
Next ❯

Citations

Oct 6, 2007·Clinical Reviews in Allergy & Immunology·D YehudaiE Toubi
Jul 31, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Robert D SteigerwaltMarcella Nebbioso
Apr 24, 2012·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Antonio PinnaAngelo Zinellu
Dec 17, 2008·Indian Journal of Ophthalmology·Nikunj J Shah, Urmi N Shah
Aug 27, 2009·Case Reports in Medicine·Sarwat SalimWahid Hanna
Mar 28, 2012·Current Opinion in Ophthalmology·Paul Hahn, Sharon Fekrat
Dec 31, 2015·Retina·Mary HoJost B Jonas
May 24, 2011·Survey of Ophthalmology·Justis P Ehlers, Sharon Fekrat
Apr 20, 2010·La Revue de médecine interne·E Héron
Oct 6, 2007·American Journal of Ophthalmology·Hideki KoizumiRichard F Spaide
Dec 5, 2006·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Hasan Al-DhibiArif O Khan
Oct 19, 2011·Clinical & Experimental Ophthalmology·Ian L McAllister
Sep 30, 2018·European Journal of Haematology·Joseph J ShatzelThomas G DeLoughery
Jul 25, 2009·Deutsches Ärzteblatt International·Alireza MirshahiLars-Olof Hattenbach
Apr 10, 2021·Journal of Ophthalmic Inflammation and Infection·Gunay UludagQuan Dong Nguyen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.